Triglyceride ≥ 400 mg/dL at screening

Hypertensive patients who need antihypertensive medication except Amlodipine, β-blockers, RAS inhibitors

sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg

A history of rhabdomyolysis, myopathy

Patient with hypersensitivity to Statin or Amlodipine

Patients undergoing eGFR \<30 mL/min/1.73 m2 (MDRD) at screening

AST(Aspartate Aminotransferase) or ALT(Alanine Aminotransferase) level ≥ 3x ULN (upper limit of normal range) or active liver disease

Creatine kinase (CK) level ≥ 5x ULN (upper limit of normal range)

Contraindications stated in the Label of Rosuampin or Caduet

Those participating in other clinical trials for investigational products at screening

Patients deemed to be ineligible to participate in the trial by investigator

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia